Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of adecatumumab alone or following
FOLFOX in patients with R0 resected liver metastases from CRC (colorectal carcinoma) and to
compare the effect to FOLFOX alone.